Publication | Closed Access

Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial

HepatologyHepatitis CViral HepatitisInterferon Alpha TherapyImmunologyAntiviral TherapyHepatitisInterferon Alpha-2bLiver DiseaseLiver TransplantationMedicineChronic Hepatitis C